Next Article in Journal
Photocatalysis for Renewable Energy Production Using PhotoFuelCells
Next Article in Special Issue
Prodrug Strategies for Enhancing the Percutaneous Absorption of Drugs
Previous Article in Journal
Unstable Simple Volatiles and Gas Chromatography-Tandem Mass Spectrometry Analysis of Essential Oil from the Roots Bark of Oplopanax Horridus Extracted by Supercritical Fluid Extraction
Previous Article in Special Issue
Polylactide Conjugates of Camptothecin with Different Drug Release Abilities
Article Menu

Export Article

Open AccessArticle
Molecules 2014, 19(12), 19718-19731; doi:10.3390/molecules191219718

Synthesis and Biological Evaluation of Novel 10-Substituted-7-ethyl-10-hydroxycamptothecin (SN-38) Prodrugs

1
Beijing Institute of Pharmacology & Toxicology, 27 Tai-Ping Road, Beijing 100850, China
2
Cell Biology Laboratory of Jilin Province Tumor Institute, No 1018 Huguang Road, Changchun 130012, China
3
Tumor Centre, No.1 Hospital, Jilin University, 71 Xin-Min Street, Changchun 130012, China
These authors contributed equally to this work.
*
Authors to whom correspondence should be addressed.
Received: 29 October 2014 / Revised: 19 November 2014 / Accepted: 19 November 2014 / Published: 27 November 2014
(This article belongs to the Special Issue Prodrugs)
View Full-Text   |   Download PDF [607 KB, uploaded 27 November 2014]   |  

Abstract

In an attempt to improve the antitumor activity and reduce the side effects of irinotecan (2), novel prodrugs of SN-38 (3) were prepared by conjugating amino acids or dipeptides to the 10-hydroxyl group of SN-38 via a carbamate linkage. The synthesized compounds completely generated SN-38 in pH 7.4 buffer or in human plasma, while remaining stable under acidic conditions. All prodrug compounds demonstrated much greater in vitro antitumor activities against HeLa cells and SGC-7901 cells than irinotecan. The most active compounds, 5h, 7c, 7d, and 7f, exhibited IC50 values that were 1000 times lower against HeLa cells and 30 times lower against SGC-7901 cells than those of irinotecan, and the inhibitory activities of these prodrugs against acetylcholinesterase (AchE) were significantly reduced, with IC50 values more than 6.8 times greater than that of irinotecan. In addition, compound 5e exhibited the same level of tumor growth inhibitory activity as irinotecan (CPT-11) in a human colon xenograft model in vivo. View Full-Text
Keywords: antitumor agent; camptothecins; prodrugs; SN-38 antitumor agent; camptothecins; prodrugs; SN-38
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Zhou, M.; Liu, M.; He, X.; Yu, H.; Wu, D.; Yao, Y.; Fan, S.; Zhang, P.; Shi, W.; Zhong, B. Synthesis and Biological Evaluation of Novel 10-Substituted-7-ethyl-10-hydroxycamptothecin (SN-38) Prodrugs. Molecules 2014, 19, 19718-19731.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top